Aprea Therapeutics Net Tangible Assets

Aprea Therapeutics (APRE) currently reports a net tangible assets of $38M as of June 2026. That compares with $13M in the prior-year period — up 186.8% year over year. Use the charts on this page to explore Aprea Therapeutics's net tangible assets history and peer comparisons.

Aprea Therapeutics's net tangible assets increased from $13M to $38M — a 186.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aprea Therapeutics reported $38M in net tangible assets as of June 2026. That compares with $13M in the prior-year period — up 186.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $38M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aprea Therapeutics, and consider following APRE for alerts when major investors trade the stock.

Aprea Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $38M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing APRE with unrelated industries.